Published in BMC Public Health on February 08, 2014
Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care (2004) 75.82
EuroQol--a new facility for the measurement of health-related quality of life. Health Policy (1990) 59.70
CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ (2010) 28.70
CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ (2010) 22.34
Inflammation and insulin resistance. J Clin Invest (2006) 18.76
The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care (2001) 15.36
Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med (2000) 12.83
The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories. Behav Res Ther (1995) 11.36
Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry (2010) 8.02
The short-form version of the Depression Anxiety Stress Scales (DASS-21): construct validity and normative data in a large non-clinical sample. Br J Clin Psychol (2005) 6.00
The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care (2005) 5.80
Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia (2006) 4.71
Do stress reactions cause abdominal obesity and comorbidities? Obes Rev (2001) 4.34
Executive summary: Standards of medical care in diabetes--2010. Diabetes Care (2010) 3.76
Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment. Biol Psychiatry (2003) 3.48
Depression, self-care, and medication adherence in type 2 diabetes: relationships across the full range of symptom severity. Diabetes Care (2007) 3.40
The Single Item Literacy Screener: evaluation of a brief instrument to identify limited reading ability. BMC Fam Pract (2006) 3.23
Depression and all-cause and coronary heart disease mortality among adults with and without diabetes. Diabetes Care (2005) 3.13
The relationship of depressive symptoms to symptom reporting, self-care and glucose control in diabetes. Gen Hosp Psychiatry (2003) 3.13
How many days of pedometer monitoring predict weekly physical activity in adults? Prev Med (2005) 2.97
Depression in diabetic patients: the relationship between mood and glycemic control. J Diabetes Complications (2005) 2.81
National standards for diabetes self-management education. Diabetes Care (2008) 2.60
Levels and risks of depression and anxiety symptomatology among diabetic adults. Diabetes Care (1997) 2.32
Association between physical activity and mental disorders among adults in the United States. Prev Med (2003) 2.22
The Diabetes Empowerment Scale-Short Form (DES-SF). Diabetes Care (2003) 2.15
Prevalence of depression in adults with diabetes. An epidemiological evaluation. Diabetes Care (1993) 2.13
Predictors of health care costs in adults with diabetes. Diabetes Care (2005) 1.98
Chronic disease self-management education programs: challenges ahead. Med J Aust (2007) 1.92
The economic costs of undiagnosed diabetes. Popul Health Manag (2009) 1.74
Rising incidence of type 2 diabetes in children in the U.K. Diabetes Care (2007) 1.72
The association between depression and health-related quality of life in people with type 2 diabetes: a systematic literature review. Diabetes Metab Res Rev (2010) 1.66
Testing a new cognitive behavioural treatment for obesity: A randomized controlled trial with three-year follow-up. Behav Res Ther (2010) 1.43
The role of adherence in mediating the relationship between depression and health outcomes. J Psychosom Res (2002) 1.19
Association of major depression and mortality in Stage 5 diabetic chronic kidney disease. Gen Hosp Psychiatry (2010) 1.17
The Demoralization Scale: a report of its development and preliminary validation. J Palliat Care (2004) 1.02
Presentation and 5-year follow-up of type 2 diabetes mellitus in African-American and Caribbean-Hispanic adolescents. Horm Res (2003) 0.96
Depressive symptoms in the first year from diagnosis of Type 2 diabetes: results from the DESMOND trial. Diabet Med (2010) 0.90
Effects of the Diabetes Manual 1:1 structured education in primary care. Diabet Med (2008) 0.86
Cost-effectiveness of usual general practitioner care with or without antidepressant medication for patients with minor or mild-major depression. J Affect Disord (2008) 0.84
Risk factors for gestational diabetes mellitus: implications for the application of screening guidelines. Aust N Z J Obstet Gynaecol (2011) 1.94
Hypericum perforatum with Vitex agnus-castus in menopausal symptoms: a randomized, controlled trial. Menopause (2009) 1.55
Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp. Hum Reprod (2013) 1.55
Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev (2011) 1.47
Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society. Fertil Steril (2008) 1.44
A systematic review of interventions aimed at the prevention of weight gain in adults. Public Health Nutr (2009) 1.30
Measuring physical activity during pregnancy. Int J Behav Nutr Phys Act (2011) 1.22
Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev (2011) 1.22
Anxiety and depression in polycystic ovary syndrome: a comprehensive investigation. Fertil Steril (2010) 1.12
Weight, physical activity and dietary behavior change in young mothers: short term results of the HeLP-her cluster randomized controlled trial. Nutr J (2009) 1.08
Effects of exercise on insulin resistance and body composition in overweight and obese women with and without polycystic ovary syndrome. J Clin Endocrinol Metab (2010) 1.05
Aromatase inhibitors for PCOS: a systematic review and meta-analysis. Hum Reprod Update (2012) 1.04
Exercise therapy in polycystic ovary syndrome: a systematic review. Hum Reprod Update (2010) 1.03
Dose adjustment for normal eating (DAFNE) - an audit of outcomes in Australia. Med J Aust (2010) 1.03
The effects of soy protein containing isoflavones on lipids and indices of bone resorption in postmenopausal women. Clin Endocrinol (Oxf) (2003) 0.99
Preventing weight gain: the baseline weight related behaviors and delivery of a randomized controlled intervention in community based women. BMC Public Health (2009) 0.97
Are we drawing the right conclusions from randomised placebo-controlled trials? A post-hoc analysis of data from a randomised controlled trial. BMC Med Res Methodol (2009) 0.95
Dietary composition in the treatment of polycystic ovary syndrome: a systematic review to inform evidence-based guidelines. J Acad Nutr Diet (2013) 0.92
Polycystic ovary syndrome and weight management. Womens Health (Lond Engl) (2010) 0.92
The impact of intensified exercise training on insulin resistance and fitness in overweight and obese women with and without polycystic ovary syndrome. Clin Endocrinol (Oxf) (2012) 0.91
Optimizing healthy gestational weight gain in women at high risk of gestational diabetes: a randomized controlled trial. Obesity (Silver Spring) (2013) 0.91
Prevalence of infertility and use of fertility treatment in women with polycystic ovary syndrome: data from a large community-based cohort study. J Womens Health (Larchmt) (2015) 0.90
Retinol-binding protein 4 and insulin resistance in polycystic ovary syndrome. Diabetes Care (2008) 0.88
Polycystic ovary syndrome - an update. Aust Fam Physician (2012) 0.86
Vitex agnus-castus (Chaste-Tree/Berry) in the treatment of menopause-related complaints. J Altern Complement Med (2009) 0.85
Effectiveness and implementation of an obesity prevention intervention: the HeLP-her Rural cluster randomised controlled trial. BMC Public Health (2014) 0.85
Physical activity and mental health in women with polycystic ovary syndrome. BMC Womens Health (2014) 0.85
The treatment of infertility in polycystic ovary syndrome: a brief update. Aust N Z J Obstet Gynaecol (2012) 0.84
Polycystic ovary syndrome and anti-Müllerian hormone: role of insulin resistance, androgens, obesity and gonadotrophins. Clin Endocrinol (Oxf) (2014) 0.84
Effects of a combination of Hypericum perforatum and Vitex agnus-castus on PMS-like symptoms in late-perimenopausal women: findings from a subpopulation analysis. J Altern Complement Med (2009) 0.83
The impact of glycaemic control on outcomes in patients with end-stage renal disease and type 2 diabetes. Nephrology (Carlton) (2008) 0.83
How effective is self-weighing in the setting of a lifestyle intervention to reduce gestational weight gain and postpartum weight retention? Aust N Z J Obstet Gynaecol (2014) 0.83
Status of clomiphene citrate and metformin for infertility in PCOS. Trends Endocrinol Metab (2012) 0.83
Metformin versus clomiphene citrate for infertility in non-obese women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update (2012) 0.82
Vitex agnus-castus extracts for female reproductive disorders: a systematic review of clinical trials. Planta Med (2012) 0.82
Diabetes risk score in the diagnostic categories of polycystic ovary syndrome. Fertil Steril (2011) 0.81
A comprehensive assessment of endothelial function in overweight women with and without polycystic ovary syndrome. Clin Sci (Lond) (2009) 0.81
Predictors of placebo response in a randomized, controlled trial of phytotherapy in menopause. Menopause (2009) 0.80
Vascular function in the diagnostic categories of polycystic ovary syndrome. Hum Reprod (2011) 0.80
Pigment epithelium-derived factor, insulin sensitivity, and adiposity in polycystic ovary syndrome: impact of exercise training. Obesity (Silver Spring) (2012) 0.80
Limiting postpartum weight retention through early antenatal intervention: the HeLP-her randomised controlled trial. Int J Behav Nutr Phys Act (2014) 0.80
Dietary composition in the treatment of polycystic ovary syndrome: a systematic review to inform evidence-based guidelines. Hum Reprod Update (2013) 0.78
Relationship of waist and hip circumference with coagulation and fibrinolysis in postmenopausal women. Clin Sci (Lond) (2007) 0.78
Mental health and physical activity in women with polycystic ovary syndrome: a brief review. Sports Med (2015) 0.76
Polycystic ovary syndrome and abnormal glucose tolerance. Med J Aust (2007) 0.75
Lost and found: improving ascertainment of refugee-background Australians in population datasets. Comment. Med J Aust (2013) 0.75
Response to 'insulin sensitivity and leptin in women with Polycystic Ovary Syndrome (PCOS)'. Clin Endocrinol (Oxf) (2015) 0.75
Alcohol taxation policy in Australia: public health imperatives for action. Comment. Med J Aust (2009) 0.75
Insulin levels, insulin resistance and the use of metformin in polycystic ovary syndrome. Med J Aust (2007) 0.75
High incidence of hypoglycemia from an audit of glycemic control and management in patients with diabetes in a cardiac unit. Front Endocrinol (Lausanne) (2013) 0.75
Skin lightening cream: an emerging medical challenge. Med J Aust (2012) 0.75
Assessing self-efficacy and self-help methods in women with and without Polycystic Ovary Syndrome. Behav Med (2013) 0.75
Erratum: Optimizing healthy gestational weight gain in women at high risk of gestational diabetes: A randomized controlled trial. Obesity (Silver Spring) (2016) 0.75
Health-related behaviors in women with lifestyle-related diseases. Behav Med (2012) 0.75
Metformin in women with PCOS, cons. Endocrine (2014) 0.75